Latest filing published 15 May 2026 for Dawnrays Pharmaceutical (Holdings) Ltd., €127k.
Insider track record
No signal scores available.
Yu Liwei: trading record in brief
Yu Liwei is a declared insider of Dawnrays Pharmaceutical (Holdings) Ltd. (chief executive), with filings sourced from HKEX. Between 27 August 2025 and 14 May 2026, the trades on record add up to 2 filings.
No open-market purchase appears, only 1 sale. No amount is published for 1 filing, which the totals therefore leave out. 2026 to date brings no purchases and 1 sale.
Most recently, on 15 May 2026, the filings show a transaction worth €127k in Dawnrays Pharmaceutical (Holdings) Ltd. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Yu Liwei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,284,000 shares@ HK$0.900.076% mcap100.0% of flowShareXHKGHKEX:DA20260514E00636
- 1,000,000 sharesShareXHKGHKEX:DA20260304E00301
2 of 2 declarations
